Iterum Therapeutics (ITRM) Receivables - Other (2017 - 2022)
Historic Receivables - Other for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $81000.0.
- Iterum Therapeutics' Receivables - Other fell 4044.12% to $81000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $81000.0, marking a year-over-year decrease of 4044.12%. This contributed to the annual value of $290000.0 for FY2021, which is N/A changed from last year.
- Latest data reveals that Iterum Therapeutics reported Receivables - Other of $81000.0 as of Q3 2022, which was down 4044.12% from $123000.0 recorded in Q2 2022.
- In the past 5 years, Iterum Therapeutics' Receivables - Other registered a high of $290000.0 during Q4 2021, and its lowest value of $7000.0 during Q4 2019.
- In the last 5 years, Iterum Therapeutics' Receivables - Other had a median value of $123000.0 in 2022 and averaged $123400.0.
- As far as peak fluctuations go, Iterum Therapeutics' Receivables - Other tumbled by 9556.96% in 2019, and later skyrocketed by 55384.62% in 2021.
- Iterum Therapeutics' Receivables - Other (Quarter) stood at $158000.0 in 2018, then plummeted by 95.57% to $7000.0 in 2019, then soared by 85.71% to $13000.0 in 2020, then soared by 2130.77% to $290000.0 in 2021, then crashed by 72.07% to $81000.0 in 2022.
- Its last three reported values are $81000.0 in Q3 2022, $123000.0 for Q2 2022, and $100000.0 during Q1 2022.